157 related articles for article (PubMed ID: 34010151)
1. SHMT2 expression as a diagnostic and prognostic marker for thyroid cancer.
Jin M; Lee WK; You MH; Jang A; Cheng SY; Kim WG; Jeon MJ; Lee YM
Endocr Connect; 2021 Jun; 10(6):630-636. PubMed ID: 34010151
[TBL] [Abstract][Full Text] [Related]
2. SHMT2 Induces Stemness and Progression of Head and Neck Cancer.
Jin Y; Jung SN; Lim MA; Oh C; Piao Y; Kim HJ; Nguyena Q; Kang YE; Chang JW; Won HR; Koo BS
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077112
[TBL] [Abstract][Full Text] [Related]
3. The expression and clinical significance of serine hydroxymethyltransferase2 in gastric cancer.
Shan Y; Liu D; Li Y; Wu C; Ye Y
PeerJ; 2024; 12():e16594. PubMed ID: 38188143
[TBL] [Abstract][Full Text] [Related]
4. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
[TBL] [Abstract][Full Text] [Related]
5. Long Non-coding RNA Expression in Anaplastic Thyroid Carcinomas.
Wang Y; Hardin H; Chu YH; Esbona K; Zhang R; Lloyd RV
Endocr Pathol; 2019 Dec; 30(4):262-269. PubMed ID: 31468286
[TBL] [Abstract][Full Text] [Related]
6. High Expression of Serine Hydroxymethyltransferase 2 Indicates Poor Prognosis of Gastric Cancer Patients.
Shi H; Fang X; Li Y; Zhang Y
Med Sci Monit; 2019 Oct; 25():7430-7438. PubMed ID: 31581160
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancer.
Wang H; Chong T; Li BY; Chen XS; Zhen WB
Biol Res; 2020 Oct; 53(1):46. PubMed ID: 33066813
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker.
Zhang L; Chen Z; Xue D; Zhang Q; Liu X; Luh F; Hong L; Zhang H; Pan F; Liu Y; Chu P; Zheng S; Lou G; Yen Y
Oncol Rep; 2016 Nov; 36(5):2489-2500. PubMed ID: 27666119
[TBL] [Abstract][Full Text] [Related]
9. Increased Expression of SHMT2 Is Associated With Poor Prognosis and Advanced Pathological Grade in Oral Squamous Cell Carcinoma.
Wu ZZ; Wang S; Yang QC; Wang XL; Yang LL; Liu B; Sun ZJ
Front Oncol; 2020; 10():588530. PubMed ID: 33163414
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of SHMT2 Predicts a Poor Prognosis and Promotes Tumor Cell Growth in Bladder Cancer.
Zhang P; Yang Q
Front Genet; 2021; 12():682856. PubMed ID: 34149818
[TBL] [Abstract][Full Text] [Related]
11. High expression of SHMT2 is correlated with tumor progression and predicts poor prognosis in gastrointestinal tumors.
Liu Y; Yin C; Deng MM; Wang Q; He XQ; Li MT; Li CP; Wu H
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9379-9392. PubMed ID: 31773687
[TBL] [Abstract][Full Text] [Related]
12. Expression of serine/glycine metabolism-related proteins is different according to the thyroid cancer subtype.
Sun WY; Kim HM; Jung WH; Koo JS
J Transl Med; 2016 Jun; 14(1):168. PubMed ID: 27277113
[TBL] [Abstract][Full Text] [Related]
13. Biotinidase is a novel marker for papillary thyroid cancer aggressiveness.
So AK; Kaur J; Kak I; Assi J; MacMillan C; Ralhan R; Walfish PG
PLoS One; 2012; 7(7):e40956. PubMed ID: 22911723
[TBL] [Abstract][Full Text] [Related]
14. Noncoding RNAs in Papillary Thyroid Cancer: Interaction with Cancer-Associated Fibroblasts (CAFs) in the Tumor Microenvironment (TME) and Regulators of Differentiation and Lymph Node Metastasis.
Dadafarin S; Carnazza M; Islam HK; Moscatello A; Tiwari RK; Geliebter J
Adv Exp Med Biol; 2021; 1350():145-155. PubMed ID: 34888848
[TBL] [Abstract][Full Text] [Related]
15. Identification of an immune-related signature indicating the dedifferentiation of thyroid cells.
Wang X; Peng W; Li C; Qin R; Zhong Z; Sun C
Cancer Cell Int; 2021 Apr; 21(1):231. PubMed ID: 33892730
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of mitochondrial serine hydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas.
Wu M; Wanggou S; Li X; Liu Q; Xie Y
Onco Targets Ther; 2017; 10():3781-3788. PubMed ID: 28794642
[TBL] [Abstract][Full Text] [Related]
17. Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma.
Luo L; Zheng Y; Lin Z; Li X; Li X; Li M; Cui L; Luo H
J Immunol Res; 2021; 2021():6647122. PubMed ID: 33928169
[TBL] [Abstract][Full Text] [Related]
18. Not the same thing: metastatic PTCs have a different background than ATCs.
de Biase D; Torricelli F; Ragazzi M; Donati B; Kuhn E; Visani M; Acquaviva G; Pession A; Tallini G; Piana S; Ciarrocchi A
Endocr Connect; 2018 Dec; 7(12):1370-1379. PubMed ID: 30400028
[TBL] [Abstract][Full Text] [Related]
19. PLEKHS1 Over-Expression is Associated with Metastases and Poor Outcomes in Papillary Thyroid Carcinoma.
Xing X; Mu N; Yuan X; Wang N; Juhlin CC; Strååt K; Larsson C; Xu D
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32752127
[TBL] [Abstract][Full Text] [Related]
20. Positive correlation between expression level of mitochondrial serine hydroxymethyltransferase and breast cancer grade.
Yin K
Onco Targets Ther; 2015; 8():1069-74. PubMed ID: 25999742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]